HowieR.N., LigginsG.C.The New Zealand study of antepartum glucocorticoid treatment. In: FarrellP.M. ed., Lung Development: Biological and Clinical Perspectives. Vol 2; Neonatal Respiratory Distress. Academic Press, New York, 255.
5.
KonstamM.A., SalemD.N., IsnerJ.M.Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: End-systolic pressure-volume relation. Am J Cardiol1984; 54: 132–136.
6.
McGoonM.D., VlietstraR.E.Vasodilator therapy for primary pulmonary hypertension. Mayo Clin Proc1984; 59: 672–677.
7.
FisherJ., BorerJ.S., MosesJ.W.Haemodynamic effects of nifedipine versus hydrallazine in primary pulmonary hypertension. Am J Cardiol1984; 54: 646–650.
8.
RichS., D'AlonzoG.E., DantzkerD.R.Magnitude and implications of spontaneous haemodynamic variability in primary pulmonary hypertension. Am J Cardiol1985; 55: 159–163.
9.
RichS., BrundageB.H.Primary pulmonary hypertension. Current update. JAMA1984; 251, 17: 2252–2254.